Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Applied Biology and Corpometria Institute to launch anti-androgen clinical study for COVID-19…
Discovery potentially links SARS-CoV-2 infectivity to androgens, the same hormones implicated in male pattern baldness and…
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData
Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis
Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial
The companies expect that a conclusive readout on efficacy is likely by the end of October
Gilead may soon buy Immunomedics in deal over $20 billion
The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports
Emerging contaminants and regulating them effectively
Tarun Anumol, Director of Global Environment & Food Applied Markets at Agilent Technologies points out that to reduce or…
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so
We are prepared to take on significant volumes from pharma partners working on COVID-19 vaccines
Megan Williamson, Head of Sales, Americas Datwyler elaborates how Datwyler is gearing up to meet the requirements of pharma…
COVAXIN demonstrates protective efficacy in animal studies: Bharat Biotech
A two-dose vaccination regimen, administered in 20 rhesus macques, showed increasing SARS-CoV-2 specific IgG and neutralizing…
NII’s COVID-19 vaccine candidate exhibits positive results in immunogenicity study on mice
The Director of the Institute said that more tests need to be done on mice on a larger scale now and it is expected to start next…
Boehringer Ingelheim and Click Therapeutics join hands for CT-155, digital therapeutic for…
Under the terms of the partnership agreement, Click Therapeutics will be primarily responsible for research and development…